Ultracef en es it fr

Ultracef Brand names, Ultracef Analogs

Ultracef Brand Names Mixture

  • None

Ultracef Chemical_Formula


Ultracef RX_link


Ultracef fda sheet

Ultracef msds (material safety sheet)

Ultracef Synthesis Reference

L. B. Crast, Jr., U.S. Pat. 3,489,752 (1969)

Ultracef Molecular Weight

363.389 g/mol

Ultracef Melting Point


Ultracef H2O Solubility

1110 mg/L

Ultracef State


Ultracef LogP


Ultracef Dosage Forms

Capsule; Tablet; Oral liquid

Ultracef Indication

For the treatment of the following infections (skin, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staphylococci and Streptococcus pyogenes

Ultracef Pharmacology

Cefadroxil, a first-generation cephalosporin antibiotic, is used to treat urinary tract infections, skin and skin structure infections, pharyngitis, and tonsillitis.

Ultracef Absorption

Cefadroxil is well absorbed on oral administration; food does not interfere with its absorption.

Ultracef side effects and Toxicity

Nausea, vomiting, diarrhoea, allergic rashes may occur

Ultracef Patient Information

Patients should be counseled that intibacterial drugs including DURICEF should only be used to treat bacterial infections. They do not treat viral infections (eg. the common cold). When DURICEF is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelyhood that bacteria will develop resistance and will not be treatable by DURICEF or other antibacterial drugs in the future.

Ultracef Organisms Affected

Enteric bacteria and other eubacteria